loadpatents
name:-0.038632154464722
name:-0.024887084960938
name:-0.010504007339478
White; Jay A. Patent Filings

White; Jay A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for White; Jay A..The latest application filed is for "stabilized modified release vitamin d formulation and method of administering same".

Company Profile
11.24.34
  • White; Jay A. - Newmarket CA
  • White; Jay A. - Kingston CA
  • White; Jay A. - Ontario CA
  • White, Jay A. - Kingston Ontario CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same
App 20220125806 - White; Jay A. ;   et al.
2022-04-28
Stabilized modified release Vitamin D formulation and method of administering same
Grant 11,253,528 - White , et al. February 22, 2
2022-02-22
Methods for controlled release oral dosage of a vitamin D compound
Grant 11,154,509 - Bishop , et al. October 26, 2
2021-10-26
Adjunctive Therapy With 25-Hydroxyvitamin D And Articles Therefor
App 20210260079 - Petkovich; P. Martin ;   et al.
2021-08-26
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
Grant 11,007,205 - Petkovich , et al. May 18, 2
2021-05-18
Adjunctive Therapy With 25-hydroxyvitamin D
App 20200253988 - Kind Code
2020-08-13
Adjunctive Therapy With 25-hydroxyvitamin D And Articles Therefor
App 20200101089 - Petkovich; P. Martin ;   et al.
2020-04-02
Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same
App 20190374555 - White; Jay A. ;   et al.
2019-12-12
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
Grant 10,493,084 - Petkovich , et al. De
2019-12-03
Stabilized modified release vitamin D formulation and method of administering same
Grant 10,357,502 - White , et al. July 23, 2
2019-07-23
Stabilized modified release vitamin D formulation and method of administering same
Grant 10,350,224 - White , et al. July 16, 2
2019-07-16
Stabilized modified release vitamin D formulation and method of administering same
Grant 10,300,078 - White , et al.
2019-05-28
Adjunctive Therapy with 25-Hydroxyvitamin D and Articles Therefor
App 20190142847 - Petkovich; P. Martin ;   et al.
2019-05-16
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
Grant 10,220,047 - Petkovich , et al.
2019-03-05
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
App 20180271885 - White; Jay A. ;   et al.
2018-09-27
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
App 20180271884 - White; Jay A. ;   et al.
2018-09-27
Stabilized Modified Release Vitamin D Formulation and Method of Administering Same
App 20180117068 - White; Jay A. ;   et al.
2018-05-03
Adjunctive Therapy With 25-Hydroxyvitamin D
App 20180085381 - Petkovich; P. Martin ;   et al.
2018-03-29
Method for treating secondary hyperparathyroidism in CKD
Grant 9,925,147 - Bishop , et al. March 27, 2
2018-03-27
Methods for controlled release oral dosage of a vitamin D compound
Grant 9,918,940 - Bishop , et al. March 20, 2
2018-03-20
Methods for Controlled Release Oral Dosage of a Vitamin D Compound
App 20180028453 - Bishop; Charles W. ;   et al.
2018-02-01
Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor
App 20180021354 - Petkovich; P. Martin ;   et al.
2018-01-25
Stabilized modified release vitamin D formulation and method of administering same
Grant 9,861,644 - White , et al. January 9, 2
2018-01-09
Method For Treating Secondary Hyperparathyroidism In Ckd
App 20170119677 - Bishop; Charles W. ;   et al.
2017-05-04
Method For Controlled Release Oral Dosage Of A Vitamin D Compound
App 20160346299 - Bishop; Charles W. ;   et al.
2016-12-01
Method for controlled release oral dosage of a vitamin D compound
Grant 9,498,486 - Bishop , et al. November 22, 2
2016-11-22
Method for treating secondary hyperparathyroidism in CKD
Grant 9,408,858 - Bishop , et al. August 9, 2
2016-08-09
Adjunctive Therapy With 25-Hydroxyvitamin D and Articles Therefor
App 20160038514 - Petkovich; P. Martin ;   et al.
2016-02-11
Method for Treating Secondary Hyperparathyroidism in CKD
App 20150216881 - Bishop; Charles W. ;   et al.
2015-08-06
Methods for Controlled Release Oral Dosage of a Vitamin D Compound
App 20140357603 - Bishop; Charles W. ;   et al.
2014-12-04
Stabilized Modified Release Vitamin D Formulation And Method Of Administering Same
App 20140349979 - White; Jay A. ;   et al.
2014-11-27
Methods for controlled release oral dosage of a vitamin D compound
Grant 8,778,373 - Bishop , et al. July 15, 2
2014-07-15
Methods And Compositions For Reducing Parathyroid Levels
App 20130137663 - Messner; Eric J. ;   et al.
2013-05-30
Methods for Controlled Release Oral Dosage of a Vitamin D Compound
App 20130131022 - Bishop; Charles W. ;   et al.
2013-05-23
Methods and compositions for controlled release oral dosage of a vitamin D compound
Grant 8,361,488 - Bishop , et al. January 29, 2
2013-01-29
Method for treating secondary hyperparathyroidism in CKD
Grant 8,207,149 - Tabash , et al. June 26, 2
2012-06-26
25-SO.sub.2-substituted analogs of 1.mu.,25-dihydroxyvitamin D.sub.3
Grant 8,106,035 - Posner , et al. January 31, 2
2012-01-31
Method for Treating Secondary Hyperparathyroidism in CKD
App 20120015916 - Tabash; Samir P. ;   et al.
2012-01-19
Retinoid metabolizing protein
App 20100203511 - Petkovich; P. Martin ;   et al.
2010-08-12
P450rai-2 (p450 Cytochrome 26b), Encoding Nucleic Acid Molecules And Methods And Uses Thereof
App 20100008902 - White; Jay A. ;   et al.
2010-01-14
P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
Grant 7,579,329 - White , et al. August 25, 2
2009-08-25
Methods And Compositions For Controlled Release Oral Dosage Of A Vitamin D Compound
App 20090176748 - Tabash; Samir P. ;   et al.
2009-07-09
Antibodies to retinoid metabolizing protein
Grant 7,473,422 - Petkovich , et al. January 6, 2
2009-01-06
Retinoid metabolizing protein
Grant 7,335,484 - Petkovich , et al. February 26, 2
2008-02-26
P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
App 20060275300 - White; Jay A. ;   et al.
2006-12-07
P450RAI-2(P450 Cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof
Grant 7,115,558 - White , et al. October 3, 2
2006-10-03
Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin D3
Grant 6,982,258 - Posner , et al. January 3, 2
2006-01-03
Retinoid metabolizing protein
Grant 6,861,238 - Petkovich , et al. March 1, 2
2005-03-01
Retinoid metabolizing protein
App 20040259074 - Petkovich, P. Martin ;   et al.
2004-12-23
Retinoid metabolizing protein
App 20040235057 - Petkovich, P. Martin ;   et al.
2004-11-25
25-SO2-Substituted analogs of 1mu,25-dihydroxyvitamin D3
App 20040224930 - Posner, Gary H. ;   et al.
2004-11-11
P450rai-2(p450 cytochrome 26b),encoding nucleic acid molecules and methods and uses thereof
App 20040131617 - White, Jay A. ;   et al.
2004-07-08
Thymus expressed human cytochrome p450(p450tec)
App 20030190642 - Jones, Glenville ;   et al.
2003-10-09
Low-calcemic oxime analogs of 1alpha,25-dihydroxy vitamin D3
App 20030171342 - Posner, Gary ;   et al.
2003-09-11
24-sulfur-substituted analogs of 1alpha, 25-dihydroxy vitamin D3
App 20030149005 - Posner, Gary H. ;   et al.
2003-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed